Human platelet calcium mobilisation in response to β-amyloid (25-35):: buffer dependency and unchanged response in Alzheimer's disease

被引:10
|
作者
Hedin, HLM [1 ]
Eriksson, S
Fowler, CJ
机构
[1] Umea Univ, Dept Pharmacol & Clin Neurosci, SE-90187 Umea, Sweden
[2] Umea Univ, Dept Community Med & Rehabil, SE-90187 Umea, Sweden
关键词
Alzheimer's disease; U-73122; amyloid beta peptides; platelets; serotonin;
D O I
10.1016/S0197-0186(00)00068-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the present study, the effects of beta -amyloid (25-35) (A beta (25-35)) upon calcium signalling by the human platelet has been investigated. When assays were conducted using HEPES buffers, A beta (25-35), but not the inactive peptide A beta (35-25), produced a robust increase in intracellular calcium that remained after removal of extracellular calcium but was abolished by the phospholipase C inhibitor U-73122. There was no significant difference bt tween the calcium response to A beta (25-35) in platelets from patients with Alzheimer's disease and from age-matched controls. In contrast to the robust effects on calcium mobilisation in HEPES buffers, very little calcium response to A beta (25-35) was seen when Krebs (pH 7.8) buffer was used. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:145 / 151
页数:7
相关论文
共 50 条
  • [41] Cellular response to β-amyloid neurotoxicity in Alzheimer's disease and implications in new therapeutics
    Zhang, Haolin
    Li, Xianghua
    Wang, Xiaoli
    Xu, Jiayu
    Elefant, Felice
    Wang, Juan
    ANIMAL MODELS AND EXPERIMENTAL MEDICINE, 2023, 6 (01) : 3 - 9
  • [42] The Neuroinflammatory Response in Plaques and Amyloid Angiopathy in Alzheimer's Disease: Therapeutic Implications
    Rozemuller, Annemieke J. M.
    van Gool, Willem A.
    Eikelenboom, Piet
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2005, 4 (03) : 223 - 233
  • [43] T cell response to amyloid-β and to mitochondrial antigens in Alzheimer's disease
    Giubilei, F
    Antonini, G
    Montesperelli, C
    Sepe-Monti, M
    Cannoni, S
    Pichi, A
    Tisei, P
    Casini, AR
    Buttinelli, C
    Prencipe, M
    Salvetti, M
    Ristori, G
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2003, 16 (01) : 35 - 38
  • [44] Cellular response to β-amyloid neurotoxicity in Alzheimer's disease and implications in new therapeutics
    Haolin Zhang
    Xianghua Li
    Xiaoli Wang
    Jiayu Xu
    Felice Elefant
    Juan Wang
    Animal Models and Experimental Medicine, 2023, (01) : 3 - 9
  • [45] In vitro antiaggregation and deaggregation potential of Rhizophora mucronata and its bioactive compound (+)- catechin against Alzheimer's beta amyloid peptide (25-35)
    Suganthy, Natarajan
    Malar, Dicson Sheeja
    Devi, Kasi Pandima
    NEUROLOGICAL RESEARCH, 2016, 38 (12) : 1041 - 1051
  • [46] Vitamin E protects against Alzheimer's amyloid peptide (25-35)-induced changes in neocortical synaptosomal membrane lipid structure and composition
    Koppal, T
    Subramaniam, R
    Drake, J
    Prasad, MR
    Dhillon, H
    Butterfield, DA
    BRAIN RESEARCH, 1998, 786 (1-2) : 270 - 273
  • [47] Five-mer peptides, inhibitor of amyloid-beta 25-35 aggregation, improve short-term memory deficits in amyloid-beta 25-35-induced Alzheimer's model mice
    Nakamura, Rina
    Higashi, Youichirou
    Konishi, Motomi
    Saito, Motoaki
    Akizawa, Toshifumi
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [48] Alzheimer's disease related amyloid beta release from human neuroblastoma cells in response to intermittent hypoxia
    Menal, Maria Jose
    Falcones, Bryan
    Pinol, Gerard
    Farre, Ramon
    Almendros, Isaac
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [49] Amyloid β-Peptide 25-35 Self-Assembly and Its Inhibition: A Model Undecapeptide System to Gain Atomistic and Secondary Structure Details of the Alzheimer's Disease Process and Treatment
    Naldi, Marina
    Fiori, Jessica
    Pistolozzi, Marco
    Drake, Alex F.
    Bertucci, Carlo
    Wu, Rongliang
    Mlynarczyk, Krzysztof
    Filipek, Slawomir
    De Simone, Angela
    Andrisano, Vincenza
    ACS CHEMICAL NEUROSCIENCE, 2012, 3 (11): : 952 - 962
  • [50] GSK-3β as a target for apigenin-induced neuroprotection against Aβ 25-35 in a rat model of Alzheimer's disease
    Alsadat, Alireza Moein
    Nikbakht, Farnaz
    Nia, Hadiseh Hossein
    Golab, Fereshteh
    Khadem, Yasaman
    Barati, Mahmoud
    Vazifekhah, Somayeh
    NEUROPEPTIDES, 2021, 90